Viper ULTRA tromboliz kateteri
An ultra üçün ixtisaslaşdırılmış infuziya kateteri birbaşa trombolitik çatdırılma, xüsusiyyət çox deşikli böyük laxtalanma seqmentləri arasında dərmanları bərabər paylamaq üçün dizayn.
The Viper® Ultrasonic Pharmacomechanical Thrombolysis System a minimal invaziv device designed to dissolve thrombi by combining targeted ultrasonic waves with controlled tPA infusion. By thinning fibrin və increasing clot porosity, the system enables deeper drug penetration into the thrombus, thereby enhancing the efficacy of pharmacological therapy. This approach helps mitigate potential bleeding complications və preserves vessel integrity, offering a more refined, patient-centric strategy for acute thrombosis management.
Ultrasonic Wave Delivery
- Controlled Ultrasound: Low-power ultrasonic energy focuses on fibrin disruption, loosening the structural integrity of the clot.
- Enhanced Porosity: Breaking fibrin strands encourages tPA to penetrate deeper, ensuring thorough thrombus dissolution.
Pharmacomechanical Infusion
- tPA Administration: A site-specific delivery of tissue plasminogen activator (tPA) directly into the clot.
- Synergistic Effect: Ultrasonic micro-cavitation augments the fibrinolytic effect, requiring lower drug doses and potentially reducing hemorrhagic complications.
Gentle Mechanization
- Minimal Vessel Trauma: Ultrasonic waves are calibrated to avoid damaging valves, vessel walls, or critical structures within the venous or pulmonary vasculature.
- Reduced Bleeding Risk: Lower overall drug usage and localized infusion can curtail systemic side effects.
- Controlled Ultrasound: Low-power ultrasonic energy focuses on fibrin disruption, loosening the structural integrity of the clot.
- Enhanced Porosity: Breaking fibrin strands encourages tPA to penetrate deeper, ensuring thorough thrombus dissolution.
- tPA Administration: A site-specific delivery of tissue plasminogen activator (tPA) directly into the clot.
- Synergistic Effect: Ultrasonic micro-cavitation augments the fibrinolytic effect, requiring lower drug doses and potentially reducing hemorrhagic complications.
- Minimal Vessel Trauma: Ultrasonic waves are calibrated to avoid damaging valves, vessel walls, or critical structures within the venous or pulmonary vasculature.
- Reduced Bleeding Risk: Lower overall drug usage and localized infusion can curtail systemic side effects.
Məhsulun spesifikasiyası
Spesifikasiya | Detal / Dəyər |
Məhsulun adı | Viper ULTRA tromboliz kateteri |
Nəzərdə tutulan istifadə | Catheter-directed infusion of thrombolytics in acute or subacute thrombus (peripheral, venous, or arterial) |
Kateter Dizaynı | Multi-hole distal segment for uniform drug dispersion, possible radiopaque marker at tip |
Material | Pebax/Polyamide shaft, potentially braided or reinforced |
Xarici diametri (F) | ~4–6F (depending on infusion lumen capacity) |
İş Uzunluğu | ~80–150 cm (varies by product code) |
Infusion Ports | Distributed side ports over a defined segment for consistent thrombolytic delivery |
Bələdçi telinin Uyğunluğu | Typically 0.014” or 0.018” |
Sterillik | Steril, tək istifadə |
Raf Ömrü | Möhürlənmiş qablaşdırmada 15-25 °C temperaturda saxlandıqda ~2-3 il |
Klinik göstərişlər | Thrombolytic infusion for DVT, peripheral arterial occlusions, possibly for intra-graft thrombosis |
Əks göstərişlər | Highly calcified lesions, severe vessel tortuosity preventing safe passage, known device material allergies |
Sifariş və Ölçü Matrisi
Xarici diametri (F) | İş uzunluğu (sm) | Infusion Segment (cm) | Məhsul Kodu | Qeydlər |
4F | 80 | 10 | VPR-4F-80-10 | Smaller OD for distal or small vessel usage |
4F | 120 | 15 | VPR-4F-120-15 | Longer shaft, moderate infusion segment |
5F | 80 | 10 | VPR-5F-80-10 | Slightly larger OD for heavier clot load |
5F | 120 | 20 | VPR-5F-120-20 | Extended length with longer infusion zone |
6F | 100 | 15 | VPR-6F-100-15 | Common size for multi-level peripheral lesions |
6F | 150 | 30 | VPR-6F-150-30 | Max length, extensive infusion segment |